Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

Rebecca Robbins and Gina Kolata
Author: Rebecca Robbins and Gina Kolata

Written by

Rebecca Robbins and Gina Kolata

in

Chemotherapy, Clinical Trials, Drugs (Pharmaceuticals), Food and Drug Administration, Pancreas, Pancreatic Cancer, Regulation and Deregulation of Industry, Sasse, Benjamin E, Trump, Donald J, United States Politics and Government
←DeFi logged the most monthly exploits ever in April
Book excerpt: “A Course Called Home” by Tom Coyne→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube